University of Texas/Texas AM Investment Management Co (UTIMCO)’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,031	Closed	-$965K	–	84
2017 Q3	$965K	Hold	7,031	–	–	2.31%	11
2017 Q2	$1.36M	Hold	7,031	–	–	4.05%	9
2017 Q1	$1.31M	Buy	+7,031	New	+$1.31M	3.43%	11